Seroba
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B
Geographical Focus
United States, United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Ireland, Austria, Netherlands, Hungary, Portugal, Sweden, Belgium, Norway, Finland, Poland, Czech Republic, Slovakia
Industries Focus
- Healthcare
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Medtech
- Biotechnology
- Regenerative Medicine
- Oncology
- Neurology
- Cardiology
- Immunology
- Genomics
- Rare Diseases
- Orthopedics
Investment Size:
1,500,000 to 3,000,000 USD
Investor Details Founded: 2002
Seroba is a European life sciences venture capital firm based in Dublin, Ireland, with additional offices in Paris and Milan. The firm focuses on early-stage investments in biotechnology and medical device companies, aiming to create value by supporting innovative solutions that address unmet medical needs. Seroba's team comprises professionals with deep industry and operational experience, leveraging an extensive global network to assist entrepreneurs in building world-class businesses around extraordinary science.
The firm's investment strategy centers on backing cutting-edge biotech and medtech innovations that have the potential to transform patient treatment. Seroba's portfolio includes companies developing novel therapeutics and medical devices across various therapeutic areas, such as oncology, neurology, and rare diseases. The firm typically invests between €1.5 million and €3 million per company, targeting seed to Series B funding stages.
Seroba's track record includes successful investments in companies like Perfuze, Sibylla Biotech, Deciphex, Complement Therapeutics, and Artica Therapeutics. These investments reflect Seroba's commitment to advancing healthcare through strategic partnerships with visionary entrepreneurs and investors who share the goal of improving human health while achieving financial returns.
Requirements
- Innovative biotech and medtech companies addressing unmet medical needs
- Early-stage ventures with strong growth potential
- Entrepreneurial teams with a passion for success and a commitment to improving human health
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Perfuze
- Sibylla Biotech
- Deciphex
- Complement Therapeutics
- Artica Therapeutics
Mentioned In
-
$24.95
-
$19.95
-
$49.95
-
$39.95
-
$19.95
-
$19.95
-
$24.95
-
$99.00
-
$245.00
Claim this Investor
Are you an official representative of Seroba?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim